DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Loi S, Michiels S, Salgado R. et al.
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER Trial.
Ann Oncol 2014;
25: 1544-1550
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.